ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

PSA-based machine learning model improves prostate cancer risk stratification in a screening population

Perera, Marlon*; Mirchandani, Rohan; Papa, Nathan; Breemer, Geoff; Effeindzourou, Anna; Smith, Lewis; Swindle, Peter; Smith, Elliot
World Journal of Urology2021-6DOI: 10.1007/s00345-020-03392-9
21被引2阅读
引用收藏
分享

摘要

Context The majority of prostate cancer diagnoses are facilitated by testing serum Prostate Specific Antigen (PSA) levels. Despite this, there are limitations to the diagnostic accuracy of PSA. Consideration of patient demographic factors and biochemical adjuncts to PSA may improve prostate cancer risk stratification. We aimed to develop a contemporary, accurate and cost-effective model based on objective measures to improve the accuracy of prostate cancer risk stratification. Methods Data were collated from a local institution and combined with patient data retrieved from the Prostate, Lung, Colorectal and Ovarian Cancer screening Trial (PLCO) database. Using a dataset of 4548 patients, a machine learning model was developed and trained using PSA, free-PSA, age and free-PSA to total PSA (FTR) ratio. Results The model was trained on a dataset involving 3638 patients and was then tested on a separate set of 910 patients. The model improved prediction for prostate cancer (AUC 0.72) compared to PSA alone (AUC 0.63), age (AUC 0.52), free-PSA (AUC 0.50) and FTR alone (AUC 0.65). When an operating point is chosen such that the sensitivity of the model is 80% the specificity of the model is 45.3%. The benefit in AUC secondary to the model was related to sample size, with AUC of 0.64 observed when a subset of the cohort was assessed. Conclusions Development of a dense neural network model improved the diagnostic accuracy in screening for prostate cancer. These results demonstrate an additional utility of machine learning methods in prostate cancer risk stratification when using biochemical parameters.

学科与关键词

关键词
Prostate cancerProstate-specific membrane antigenProstate cancer screeningMachine learningArtificial intelligence
相关
加载中…
  • Optimized Identification of High-Grade Prostate Cancer by Combining Different PSA Molecular Forms and PSA Density in a Deep Learning Model
    Gentile, Francesco*; Ferro, Matteo; Della Ventura, Bartolomeo; La Civita, Evelina; Liotti, Antonietta; Cennamo, Michele; Bruzzese, Dario; Velotta, Raffaele; Terracciano, Daniela*Diagnostics, 2021, 11(2): 335.被引 13
  • Do prostate cancer risk models improve the predictive accuracy of PSA screening? A meta-analysis
    Louie, K. S.*; Seigneurin, A.; Cathcart, P.; Sasieni, P.Annals of Oncology, 2015, 26(5): 848-864.被引 135
  • Predicting the outcome of prostate biopsy in screen-positive men by a multilayer perceptron network
    Finne, P; Finne, R; Auvinen, A; Juusela, H; Aro, J; Mttnen, L; Hakama, M; Rannikko, S; Tammela, TLJ; Stenman, UHUrology, 2000, 56(3): 418-422.被引 121
查看全部 →

发表信息

论文状态
公开发表
期刊
World Journal of Urology
发表日期
2021-06
卷期
第 39 卷, 第 6 期
页码
1897-1902
DOI
10.1007/s00345-020-03392-9
语言
ENGLISH
期刊收录
NSL
期刊等级
2区
成果收录
SCIE

作者

  • P

    Perera, Marlon (通讯) (第一作者)

  • M

    Mirchandani, Rohan

查看全部 8 位作者收起作者
  • P

    Papa, Nathan

  • B

    Breemer, Geoff

  • E

    Effeindzourou, Anna

  • S

    Smith, Lewis

  • S

    Swindle, Peter

  • S

    Smith, Elliot

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417